The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-Methylpiperazin-1-yl)-6-m-tolylpyrimidin-2-ylamine ID: ALA492274
PubChem CID: 25129524
Max Phase: Preclinical
Molecular Formula: C16H21N5
Molecular Weight: 283.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(-c2cc(N3CCN(C)CC3)nc(N)n2)c1
Standard InChI: InChI=1S/C16H21N5/c1-12-4-3-5-13(10-12)14-11-15(19-16(17)18-14)21-8-6-20(2)7-9-21/h3-5,10-11H,6-9H2,1-2H3,(H2,17,18,19)
Standard InChI Key: LAKTWLGPYJCEIC-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
14.1111 -3.4541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1099 -4.2815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8247 -4.6944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5412 -4.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5383 -3.4505 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8229 -3.0414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2540 -4.6916 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2533 -5.5176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9643 -5.9288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6805 -5.5187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6812 -4.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9657 -4.2769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3941 -5.9328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8205 -2.2164 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3970 -4.6937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6826 -4.2789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9683 -4.6902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9672 -5.5161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6864 -5.9290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3977 -5.5153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6886 -6.7540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
4 7 1 0
6 1 1 0
10 13 1 0
7 8 1 0
6 14 1 0
1 2 2 0
3 4 2 0
15 16 2 0
16 17 1 0
4 5 1 0
17 18 2 0
2 3 1 0
18 19 1 0
5 6 2 0
19 20 2 0
20 15 1 0
2 15 1 0
7 12 1 0
19 21 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 283.38Molecular Weight (Monoisotopic): 283.1797AlogP: 1.79#Rotatable Bonds: 2Polar Surface Area: 58.28Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.62CX LogP: 3.00CX LogD: 2.54Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.91Np Likeness Score: -1.70
References 1. Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu H, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD.. (2008) Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands., 51 (20): [PMID:18811133 ] [10.1021/jm8005959 ]